Connect with us

Market News

ZNTL Stock Price News: 6.69% Surge

Published

on

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)’s stock price increased by 6.69% as of April 15. The previous closing price was 47.01(14th April) and thus, an increase of 3.27 happened. The closing price of April 15 was 50.28. The day’s range was between  47.26 – 51.69 and the volume was 364,234 (above average).

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)’s stock price currently stands at 50.28 and is grossing high if compared to the previous 5 days’ closing prices. 

  • Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2 trial evaluating ZN-c3 in patients with advanced solid tumors who are refractory to or ineligible for standard therapy or for whom no standard therapy is available.

  • Data were presented at the American Association of Cancer Research (AACR) Annual Meeting.

  • Zentalis’ WEE1 inhibitor, ZN-c3, posted partial responses across a slate of tumor types with a tolerable safety profile as monotherapy for solid tumor patients.

  • The drug shrank tumors in two patients: One patient had stage 4 ovarian cancer and had tried 18 lines of treatment, while the other patient had stage 4 colorectal cancer and had undergone five prior lines of treatment.

  • The ovarian cancer patient saw targeted tumors shrink by about 56%. Four weeks into treatment, it saw a “large rapid drop” in blood levels of CA-125, an antigen used to monitor certain cancers.

  • As for the colorectal cancer patient, tumors shrank by 42%, and the patient remained on treatment for about six months before the disease progressed.

  • Three other patients had their tumors shrink, too—including one with Stage IV non-small cell lung cancer (NSCLC) and two with uterine serous carcinoma.

  • The NSCLC patient had received three prior lines of therapy and, after ZN-c3 treatment, achieved an unconfirmed partial response with a 50% reduction in overall target lesions.

  • On the safety front, side effects were mostly mild to moderate, with nausea affecting about half of the 55 patients evaluated for safety, diarrhea, fatigue, and vomiting, afflicting less than one-third of them.

  • Blood-related side effects struck less than 10% of patients: 1.8% of patients suffered a low white blood cell count, 7.2% of patients had a low platelet count, and 7.2% of patients developed anemia.

  • The company initiated the Phase 1 expansion portion of the trial with the 300 mg dose earlier in 2021 and is exploring ZN-c3’s potential in combination trials, including in ovarian cancer and osteosarcoma.

  • Separately, the company has collaborated with GlaxoSmithKline plc (NYSE: GSK) to evaluate the combination of ZN-c3 and Zejula (niraparib) in patients with advanced epithelial ovarian cancer.

  • Under the terms of the non-exclusive collaboration, Zentalis is responsible for conducting the study with GSK supplying niraparib. Zentalis maintains full ownership of ZN-c3.
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Market News

Top 5 Stock Price Gainers of May 17: US Stock Market

Published

on

Consumer Automotive Finance, Inc. (OTCMKTS: NWAU)

Consumer Automotive Finance, Inc. (OTCMKTS: NWAU)’s stock price increased by 22.50%. The closing price as of May 16 was $0.0400, over which, the price increased by $0.0090 on May 17. The closing price as of May 17 stands at $0.0490. The opening price was $0.0625, the range was 0.0400 – 0.0625 and the volume was 199,804. 

 

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

The stock price of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands at $53.60 as of May 17. The price shows a growth of $8.80(19.88%) over the previous ( May 16) closing price of $44.26.  The opening price as of May 17 was $49.01; the day’s range was 48.96 – 54.25. The volume was above average, being 6,234,624.

 

Globalstar, Inc. (NYSE: GSAT)

Globalstar, Inc. (NYSE: GSAT)’s closing stock as of May 17 stands at $1.3600. The price shows a growth of $0.2200 (19.30%) over the previous ( May 16) closing price of $1.1400. May 17’s opening price was $1.1000 and the day’s range was 1.1000 – 1.3800. The volume was 24,374,234, slightly above average. 

 

Hecla Mining Company (NYSE: HL)

Hecla Mining Company (NYSE: HL)’s stock price increased by a huge amount of 16.53%. The previous price, i.e, May 16’s price was $7.56. The current price as of May 17, is $8.81 which is $1.25 more than the previous closing price. The opening price of May 17 was $7.73. The price range for the day was 7.65 – 8.88; the volume was 23,888,169.

 

Discovery, Inc. (NASDAQ: DISCB)

$80.18 is the current( as of May 17) stock price of Discovery, Inc. (NASDAQ: DISCB). The price shows a growth of $9.67 (13.71%) over the previous (May 16) closing price of $70.51.  The pre-market price as of  4:04AM EDT, May 18 remains the same as the closing price of May 17, $80.18 .

Continue Reading

Market News

TOP STOCKS GAINERS FOR MAY 12

Published

on

AbCellera Biologics Inc. (NASDAQ: ABCL)

AbCellera Biologics Inc. (NASDAQ: ABCL)’s stock price increased by 8.74% over the previous closing price of $28.25. The price, as of May 12 closing price, is $30.72. The Pre-market price is stagnant as of 4:59 AM EDT, May 13. 

 

UWM Holdings Corporation Class (NYSE: UWMC) 

UWM Holdings Corporation Class (NYSE: UWMC)’s stock price increased by 8.96% on May 12. May 12’s closing price was $0.59 more than the previous ( May 11) closing price of $6.79. The opening price of May 12 was $6.74; the range was 6.70 – 7.61 and the volume was 9,919,270. However, the Pre-market price says a different story. The price has dropped, as of 5:35 AM EDT by 3.12% and currently stands at $7.15.

 

CVR Energy, Inc. (NYSE: CVI)

CVR Energy, Inc. (NYSE: CVI)’ stock price as of May 12 was $22.77, which is $1.79 more than the previous closing price of $20.98. The day’s range was  22.02-23.90 and the volume was 1,595,046. The opening price as of May 12 was $22.96.

 

Intercorp Financial Services Inc. (NYSE: IFS)

Intercorp Financial Services Inc. (NYSE: IFS)’s stock price increased by 11.31%. The closing price as of May 12 was $29.43, which is $2.26(8.32%) more than the previous closing price of $27.17. The volume was 82,164 and the range was 27.16 – 29.86. The opening price of May 12  was $25.14. 

 

Pershing Square Tontine Holdings, Ltd. (NYSE: PSTH)

Pershing Square Tontine Holdings, Ltd. (NYSE: PSTH)’ stock price increased by a good amount of 7.33%. The closing price as of May 12 was $24.38, which is $1.75 more than the previous closing price of  $22.63. The price has dropped as of 5:17 AM EDT, May 13, Pre-market, and stands at $24.22. 

Continue Reading

Market News

TOP STOCK Market Gainers: LTCN, HL, GCPEF, ABEV, RUN

Published

on

Grayscale Litecoin Trust (OTCMKTS: LTCN)

Grayscale Litecoin Trust’s (OTCMKTS: LTCN) closing price as of May 6 was $445.99. The price hike was recorded to be 17.67%, more than the previous closing price of $379.03. The opening price was $396.00, the volume was 45,765 and the range was 379.05 – 452.12 and respectively. 

Hecla Mining Company (NYSE: HL)

Hecla Mining Company’s (NYSE: HL) closing stock price as of May 6 was $7.29. This showed a growth of 16.64% over the previous closing price of $6.25. The opening price was $6.41, with the volume being 24,884,791 and the day’s range being 6.41 – 7.32. 

GCL-Poly Energy Holdings Limited (OTCMKTS: GCPEF)

GCL-Poly Energy Holdings Limited’s (OTCMKTS: GCPEF) stock price increased by 13.33% over the previous( May 5) closing price of $0.2250. The opening price of May 6 was $0.2400. The volume was 196,480 and the day’s range was 0.2300 – 0.2600.

Ambev S.A. (NYSE: ABEV)

Ambev S.A. (NYSE: ABEV) stock price increased to $3.1200(closing price, May 6) from $2.7900(closing price, May 5). The growth percentage was recorded to be 11.83%. The opening price of May 6 was 3.0600, the volume being 62,369,302 and the range being 2.9800 – 3.1200. 

Sunrun Inc. (NASDAQ: RUN)

Sunrun Inc. (NASDAQ: RUN) stock price increased by 11.69% over the previous closing price( May 5) of $41.84. The closing price of May 6 was sighted to be $46.73. The opening price of May 6-  44.80, volume- 15,073,385 and the range- 43.29 – 46.97.

Continue Reading

Trending